NCT05319860

Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)

Effects of Aromatherapy on Chemotherapy-Induced Nausea and Vomiting: A Control Trial

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: University of Miami · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the use of aromatherapy to reduce nausea, vomiting, and the use of anti-emetic in cancer survivors undergoing moderate to highly emetogenic chemotherapy regimens.

Conditions

• Chemotherapy-induced Nausea and Vomiting

Interventions

Type	Name	Description
DRUG	Standard of Care Treatment for Chemotherapy Induced Nausea and Vomiting (CINV)	Standard of care for CINV includes anti-nausea medication as needed after chemotherapy regimen given for up to 12 weeks.
DRUG	Aromatherapy Care	An aromatherapy inhaler provided for use as needed after chemotherapy regimen given for up to 12 weeks. One normal inhale is equal to one dose of aromatherapy. Participants can use the aromatherapy as often as needed.

Timeline

• Start date: 2022-08-01
• Primary completion: 2024-04-15
• Completion: 2024-04-15
• First posted: 2022-04-08
• Last updated: 2025-04-17
• Results posted: 2025-04-17

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study